Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1959 Mar;14(1):112-6.
doi: 10.1111/j.1476-5381.1959.tb00936.x.

Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse

Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse

J G BLACKMAN et al. Br J Pharmacol Chemother. 1959 Mar.

Abstract

Gastric haemorrhage was produced regularly in mice within 6 hours of the subcutaneous injection of a large dose (2 to 10 mg./kg.) of reserpine or of deserpidine. Rescinnamine, syrosingopine (SU-3118), and tetrabenazine (Ro 1-9569) were less active. Gastric haemorrhage was also produced within 6 hours when 5-hydroxytryptamine (10 mg./kg.) was injected every half-hour. Neither reserpine nor 5-hydroxytryptamine produced gastric haemorrhage in mice which had been vagotomized by tying the oesophagus at the cardio-oesophageal junction or which had been pre-treated with iproniazid. Amphetamine was less effective than iproniazid in preventing gastric haemorrhage after reserpine, and the following drugs were ineffective: cocaine, methyl phenidate (Ritalin), amarin, caffeine, nikethamide, lysergic acid diethylamide and its 2-bromo derivative (BOL148). Gastric haemorrhage was not observed in mice which had been given substantial doses of atropine or of hexamethonium before reserpine. The incidence of haemorrhage was substantially reduced by treatment with an antacid mixture. It is concluded that reserpine-like drugs cause gastric haemorrhage by a mechanism which has an important central component and which involves the liberation of 5-hydroxytryptamine.

PubMed Disclaimer

References

    1. Science. 1955 Aug 26;122(3165):374-5 - PubMed
    1. Proc Soc Exp Biol Med. 1957 Mar;94(3):433-5 - PubMed
    1. Schweiz Med Wochenschr. 1957 Jan 12;87(2):37-9 - PubMed
    1. J Exp Med. 1957 Jun 1;105(6):509-20 - PubMed
    1. Proc Soc Exp Biol Med. 1957 Jun;95(2):392-3 - PubMed